blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3007700

EP3007700 - NEW POLYMORPHIC FORMS OF ICOTINIB PHOSPHATE AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.05.2018
Database last updated on 28.03.2026
FormerThe patent has been granted
Status updated on  26.05.2017
FormerGrant of patent is intended
Status updated on  09.02.2017
FormerRequest for examination was made
Status updated on  23.01.2017
FormerGrant of patent is intended
Status updated on  23.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
Betta Pharmaceuticals Co., Ltd.
589 Hongfeng Rd.
Yuhang
Hangzhou, Zhejiang 311100 / CN
[2016/16]
Inventor(s)01 / HU, Shaojing
Building 29
Zone B
1 North Disheng Rd.
Business Development Area, Daxing
Beijing 100176 / CN
02 / LONG, Wei
Building 29
Zone B
1 North Disheng Rd.
Business Development Area, Daxing
Beijing 100176 / CN
03 / WANG, Fei
Building 29
Zone B
1 North Disheng Rd.
Business Development Area, Daxing
Beijing 100176 / CN
04 / WANG, Yinxiang
Building 29
Zone B
1 North Disheng Rd.
Business Development Area, Daxing
Beijing 100176 / CN
05 / DING, Lieming
589 Hongfeng RD.
Yuhang
Hangzhou Zhejiang 311100 / CN
 [2016/16]
Representative(s)Hanna Moore + Curley
Garryard House
25-26 Earlsfort Terrace
Dublin 2, D02 PX51 / IE
[N/P]
Former [2017/26]Hanna Moore + Curley
Garryard House
25/26 Earlsfort Terrace
Dublin 2, D02 PX51 / IE
Former [2016/16]Walsh, Marie Goretti, et al
Hanna Moore + Curley
13 Lower Lad Lane
Dublin 2, D02 T668 / IE
Application number, filing date14810815.209.06.2014
[2016/16]
WO2014CN79488
Priority number, dateWO2013CN7709109.06.2013         Original published format: PCT/CN2013/077091
[2016/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014198211
Date:18.12.2014
Language:EN
[2014/51]
Type: A1 Application with search report 
No.:EP3007700
Date:20.04.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 18.12.2014 takes the place of the publication of the European patent application.
[2016/16]
Type: B1 Patent specification 
No.:EP3007700
Date:28.06.2017
Language:EN
[2017/26]
Search report(s)International search report - published on:CN18.12.2014
(Supplementary) European search report - dispatched on:EP11.07.2016
ClassificationIPC:A61K31/519, C07D491/056, A61P35/00
[2016/16]
CPC:
C07D491/056 (EP,RU,US); A61K31/519 (EP,RU,US); A61K45/06 (US);
A61P1/18 (EP); A61P13/08 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); C30B29/54 (US); C30B7/00 (US);
C30B7/14 (US); C07B2200/13 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/16]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NEUE POLYMORPHE FORMEN VON ICOTINIB-PHOSPHAT UND VERWENDUNGEN DAVON[2016/16]
English:NEW POLYMORPHIC FORMS OF ICOTINIB PHOSPHATE AND USES THEREOF[2016/16]
French:NOUVELLES FORMES POLYMORPHES DE PHOSPHATE D'ICOTINIB ET LEURS UTILISATIONS[2016/16]
Entry into regional phase22.12.2015National basic fee paid 
22.12.2015Search fee paid 
22.12.2015Designation fee(s) paid 
22.12.2015Examination fee paid 
Examination procedure22.12.2015Examination requested  [2016/16]
02.08.2016Amendment by applicant (claims and/or description)
24.11.2016Communication of intention to grant the patent
20.01.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
10.02.2017Communication of intention to grant the patent
17.05.2017Fee for grant paid
17.05.2017Fee for publishing/printing paid
17.05.2017Receipt of the translation of the claim(s)
Opposition(s)29.03.2018No opposition filed within time limit [2018/23]
Fees paidRenewal fee
31.03.2016Renewal fee patent year 03
17.05.2017Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.06.2014
AL28.06.2017
AT28.06.2017
CY28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
MC28.06.2017
MK28.06.2017
NL28.06.2017
PL28.06.2017
PT28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SI28.06.2017
SK28.06.2017
SM28.06.2017
TR28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
[2020/34]
Former [2020/31]HU09.06.2014
AT28.06.2017
CY28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
MC28.06.2017
MK28.06.2017
NL28.06.2017
PL28.06.2017
PT28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SI28.06.2017
SK28.06.2017
SM28.06.2017
TR28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2020/30]HU09.06.2014
AT28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
MC28.06.2017
NL28.06.2017
PL28.06.2017
PT28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SI28.06.2017
SK28.06.2017
SM28.06.2017
TR28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2020/28]AT28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
MC28.06.2017
NL28.06.2017
PL28.06.2017
PT28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SI28.06.2017
SK28.06.2017
SM28.06.2017
TR28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2020/15]AT28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
MC28.06.2017
NL28.06.2017
PL28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SI28.06.2017
SK28.06.2017
SM28.06.2017
TR28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2019/15]AT28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
MC28.06.2017
NL28.06.2017
PL28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SI28.06.2017
SK28.06.2017
SM28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2018/40]AT28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
NL28.06.2017
PL28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SI28.06.2017
SK28.06.2017
SM28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2018/21]AT28.06.2017
CZ28.06.2017
DK28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
NL28.06.2017
PL28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SK28.06.2017
SM28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2018/11]AT28.06.2017
CZ28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
NL28.06.2017
PL28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SK28.06.2017
SM28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
IS28.10.2017
Former [2018/10]AT28.06.2017
CZ28.06.2017
EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
NL28.06.2017
RO28.06.2017
RS28.06.2017
SE28.06.2017
SK28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
Former [2018/09]EE28.06.2017
FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
NL28.06.2017
RS28.06.2017
SE28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
Former [2017/52]FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
NL28.06.2017
RS28.06.2017
SE28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
Former [2017/50]FI28.06.2017
HR28.06.2017
LT28.06.2017
LV28.06.2017
RS28.06.2017
SE28.06.2017
BG28.09.2017
NO28.09.2017
GR29.09.2017
Former [2017/49]FI28.06.2017
HR28.06.2017
LT28.06.2017
NO28.09.2017
GR29.09.2017
Documents cited:Search[AD] EP2392576  (BETA PHARMA INC et al.) [AD] 1-29 * claim 1 *
 [AD] WO03082830  (BETA PHARMA INC et al.) [AD] 1-29 * compound 23 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.